Raras
Buscar doenças, sintomas, genes...
Homocistinúria sem acidúria metilmalônica
ORPHA:622CID-10 · E72.1CID-11 · 5C50.BDOENÇA RARA

A homocistinúria sem acidúria metilmalônica é um erro inato do metabolismo da vitamina B12 (cobalamina) caracterizado por anemia megaloblástica, encefalopatia e, às vezes, atraso no desenvolvimento, e associado à homocistinúria e hiperhomocisteinemia. Existem três tipos de homocistinúria sem acidúria metilmalônica; cblE, cblG e cblD-variante 1 (cblDv1).

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

A homocistinúria sem acidúria metilmalônica é um erro inato do metabolismo da vitamina B12 (cobalamina) caracterizado por anemia megaloblástica, encefalopatia e, às vezes, atraso no desenvolvimento, e associado à homocistinúria e hiperhomocisteinemia. Existem três tipos de homocistinúria sem acidúria metilmalônica; cblE, cblG e cblD-variante 1 (cblDv1).

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
<1 / 1 000 000
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
0.0
Worldwide
Casos conhecidos
73
pacientes catalogados
Início
All ages
🏥
SUS: Cobertura parcialScore: 40%
Triagem neonatal (Fase 2)Centros em: PA, PR, SC, RS, ES +8CID-10: E72.1
🇧🇷Dados SUS / DATASUS
PROCEDIMENTOS SIGTAP (7)
0202010279
Dosagem de aminoácidos (erros inatos)metabolic_test
0202010295
Dosagem de ácidos orgânicos na urinagenetic_test
0202010490
Teste de triagem para erros inatos do metabolismonewborn_screening
0202010694
Sequenciamento completo do exoma (WES)rehabilitation
0202080013
Teste do pezinho (triagem neonatal)nutritional
0301070040
Atendimento em reabilitação — doenças raras
+1 outros procedimentos
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

🧠
Neurológico
26 sintomas
🩸
Sangue
11 sintomas
🦴
Ossos e articulações
9 sintomas
👁️
Olhos
6 sintomas
📏
Crescimento
5 sintomas
🫃
Digestivo
4 sintomas

+ 25 sintomas em outras categorias

Características mais comuns

90%prev.
Hipotonia
Muito frequente (99-80%)
90%prev.
Medula óssea megaloblástica
Muito frequente (99-80%)
55%prev.
Atraso global do desenvolvimento
Frequente (79-30%)
55%prev.
Convulsão
Frequente (79-30%)
55%prev.
Atrofia cortical cerebral
Frequente (79-30%)
55%prev.
Nistagmo
Frequente (79-30%)
93sintomas
Muito frequente (2)
Frequente (6)
Ocasional (5)
Sem dados (80)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 93 características clínicas mais associadas, ordenadas por frequência.

HipotoniaHypotonia
Muito frequente (99-80%)90%
Medula óssea megaloblásticaMegaloblastic bone marrow
Muito frequente (99-80%)90%
Atraso global do desenvolvimentoGlobal developmental delay
Frequente (79-30%)55%
ConvulsãoSeizure
Frequente (79-30%)55%
Atrofia cortical cerebralCerebral cortical atrophy
Frequente (79-30%)55%

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2025
Últimos 10 anos168publicações
Pico202122 papers
Linha do tempo
2025Hoje · 2026🧪 2018Primeiro ensaio clínico📈 2021Ano de pico
Publicações por ano (últimos 10 anos)

Triagem neonatal (Teste do Pezinho)

👶
Teste: MS/MS — acilcarnitinas + ácidos orgânicos
Fase 2 do PNTNin_rollout
Incidência no Brasil: 1:20.000

A triagem neonatal permite diagnóstico precoce e início imediato do tratamento.

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

3 genes identificados com associação a esta condição. Padrão de herança: Autosomal recessive.

MTRMethionine synthaseDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Catalyzes the transfer of a methyl group from methylcob(III)alamin (MeCbl) to homocysteine, yielding enzyme-bound cob(I)alamin and methionine in the cytosol (PubMed:16769880, PubMed:17288554, PubMed:27771510). MeCbl is an active form of cobalamin (vitamin B12) used as a cofactor for methionine biosynthesis. Cob(I)alamin form is regenerated to MeCbl by a transfer of a methyl group from 5-methyltetrahydrofolate (PubMed:16769880, PubMed:17288554, PubMed:27771510). The processing of cobalamin in the

LOCALIZAÇÃO

Cytoplasm

VIAS BIOLÓGICAS (5)
Cobalamin (Cbl) metabolismMethylationSulfur amino acid metabolismDefective MTRR causes HMAERHOH GTPase cycle
MECANISMO DE DOENÇA

Homocystinuria-megaloblastic anemia, cblG type

An autosomal recessive inborn error of metabolism resulting from defects in the cobalamin-dependent pathway that converts homocysteine to methionine. It causes delayed psychomotor development, megaloblastic anemia, homocystinuria, and hypomethioninemia.

EXPRESSÃO TECIDUAL(Ubíquo)
Nervo tibial
38.4 TPM
Tireoide
33.3 TPM
Ovário
31.6 TPM
Fallopian Tube
28.9 TPM
Cervix Ectocervix
28.8 TPM
OUTRAS DOENÇAS (2)
methylcobalamin deficiency type cblGneural tube defects, folate-sensitive
HGNC:7468UniProt:Q99707
MMADHCCobalamin trafficking protein CblDDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Involved in cobalamin metabolism and trafficking (PubMed:18385497, PubMed:23415655, PubMed:24722857, PubMed:26364851). Plays a role in regulating the biosynthesis and the proportion of two coenzymes, methylcob(III)alamin (MeCbl) and 5'-deoxyadenosylcobalamin (AdoCbl) (PubMed:18385497, PubMed:23415655, PubMed:24722857). Promotes oxidation of cob(II)alamin bound to MMACHC (PubMed:26364851). The processing of cobalamin in the cytosol occurs in a multiprotein complex composed of at least MMACHC, MMA

LOCALIZAÇÃO

CytoplasmMitochondrion

VIAS BIOLÓGICAS (1)
Cobalamin (Cbl) metabolism
MECANISMO DE DOENÇA

Methylmalonic aciduria and homocystinuria, cblD type

An autosomal recessive disorder of cobalamin metabolism characterized by decreased levels of the coenzymes adenosylcobalamin (AdoCbl) and methylcobalamin (MeCbl). Clinical features include developmental delay, hyotonia, intellectual disability, seizures, and megaloblastic anemia. Laboratory studies show methylmalonic aciduria and homocystinuria.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
157.4 TPM
Fibroblastos
145.1 TPM
Artéria tibial
139.0 TPM
Músculo esquelético
127.1 TPM
Aorta
115.0 TPM
OUTRAS DOENÇAS (5)
methylmalonic aciduria and homocystinuria type cblDhomocystinuria-megaloblastic anemia cblD typeisolated methylmalonic aciduria cblD typemethylcobalamin deficiency type cblDv1
HGNC:25221UniProt:Q9H3L0
MTRRMethionine synthase reductaseDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Key enzyme in methionine and folate homeostasis responsible for the reactivation of methionine synthase (MTR/MS) activity by catalyzing the reductive methylation of MTR-bound cob(II)alamin (PubMed:17892308). Cobalamin (vitamin B12) forms a complex with MTR to serve as an intermediary in methyl transfer reactions that cycles between MTR-bound methylcob(III)alamin and MTR bound-cob(I)alamin forms, and occasional oxidative escape of the cob(I)alamin intermediate during the catalytic cycle leads to

LOCALIZAÇÃO

Cytoplasm

VIAS BIOLÓGICAS (4)
Cobalamin (Cbl) metabolismMethylationSulfur amino acid metabolismDefective MTR causes HMAG
MECANISMO DE DOENÇA

Homocystinuria-megaloblastic anemia, cblE type

An autosomal recessive inborn error of metabolism resulting from defects in the cobalamin-dependent pathway that converts homocysteine to methionine. It causes delayed psychomotor development, megaloblastic anemia, homocystinuria, and hypomethioninemia. Cells from patients with HMAE fail to incorporate methyltetrahydrofolate into methionine in whole cells, but cell extracts show normal methionine synthase activity in the presence of a reducing agent.

EXPRESSÃO TECIDUAL(Ubíquo)
Pulmão
23.0 TPM
Fibroblastos
22.4 TPM
Linfócitos
22.3 TPM
Útero
21.2 TPM
Nervo tibial
21.0 TPM
OUTRAS DOENÇAS (2)
methylcobalamin deficiency type cblEneural tube defects, folate-sensitive
HGNC:7473UniProt:Q9UBK8

Variantes genéticas (ClinVar)

590 variantes patogênicas registradas no ClinVar.

🧬 MTR: NM_000254.3(MTR):c.3550_3551del (p.Thr1184fs) ()
🧬 MTR: NM_000254.3(MTR):c.994A>G (p.Arg332Gly) ()
🧬 MTR: NM_000254.3(MTR):c.891T>A (p.Tyr297Ter) ()
🧬 MTR: NM_000254.3(MTR):c.2107C>T (p.Arg703Ter) ()
🧬 MTR: NM_000254.3(MTR):c.2925G>T (p.Trp975Cys) ()
Ver todas no ClinVar

Classificação de variantes (ClinVar)

Distribuição de 1 variantes classificadas pelo ClinVar.

1
Patogênica (100.0%)
VARIANTES MAIS SIGNIFICATIVAS
MTRR: NM_002454.3(MTRR):c.340C>T (p.Arg114Ter) [Pathogenic]

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
·Pré-clínico1
Medicamentos catalogadosEnsaios clínicos· 0 medicamentos · 1 ensaio
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Homocistinúria sem acidúria metilmalônica

Centros de Referência SUS

21 centros habilitados pelo SUS para Homocistinúria sem acidúria metilmalônica

Centros para Homocistinúria sem acidúria metilmalônica

Detalhes dos centros

Hospital Universitário Prof. Edgard Santos (HUPES)

R. Dr. Augusto Viana, s/n - Canela, Salvador - BA, 40110-060 · CNES 0003808

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do Metabolismo

Hospital de Apoio de Brasília (HAB)

AENW 3 Lote A Setor Noroeste - Plano Piloto, Brasília - DF, 70684-831 · CNES 0010456

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Estadual Infantil e Maternidade Alzir Bernardino Alves (HIABA)

Av. Min. Salgado Filho, 918 - Soteco, Vila Velha - ES, 29106-010 · CNES 6631207

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital das Clínicas da UFG

Rua 235 QD. 68 Lote Área, Nº 285, s/nº - Setor Leste Universitário, Goiânia - GO, 74605-050 · CNES 2338424

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do Metabolismo

Hospital das Clínicas da UFMG

Av. Prof. Alfredo Balena, 110 - Santa Efigênia, Belo Horizonte - MG, 30130-100 · CNES 2280167

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

NUPAD / Faculdade de Medicina UFMG

Av. Prof. Alfredo Balena, 189 - 5 andar - Centro, Belo Horizonte - MG, 30130-100 · CNES 2183226

Serviço de Referência

Rota
Erros Inatos do Metabolismo

Hospital Universitário João de Barros Barreto

R. dos Mundurucus, 4487 - Guamá, Belém - PA, 66073-000 · CNES 2337878

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital de Clínicas da Universidade Federal de Pernambuco

Av. Prof. Moraes Rego, 1235 - Cidade Universitária, Recife - PE, 50670-901 · CNES 2561492

Atenção Especializada

Rota
Erros Inatos do Metabolismo

Instituto de Medicina Integral Prof. Fernando Figueira (IMIP)

R. dos Coelhos, 300 - Boa Vista, Recife - PE, 50070-902 · CNES 0000647

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital de Clínicas da UFPR

R. Gen. Carneiro, 181 - Alto da Glória, Curitiba - PR, 80060-900 · CNES 2364980

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Universitário Pedro Ernesto (HUPE-UERJ)

Blvd. 28 de Setembro, 77 - Vila Isabel, Rio de Janeiro - RJ, 20551-030 · CNES 2280221

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do Metabolismo

Instituto Nacional de Saúde da Mulher, da Criança e do Adolescente Fernandes Figueira (IFF/Fiocruz)

Av. Rui Barbosa, 716 - Flamengo, Rio de Janeiro - RJ, 22250-020 · CNES 2269988

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Universitário Onofre Lopes (HUOL)

Av. Nilo Peçanha, 620 - Petrópolis, Natal - RN, 59012-300 · CNES 2408570

Atenção Especializada

Rota
Erros Inatos do Metabolismo

Hospital São Lucas da PUCRS

Av. Ipiranga, 6690 - Jardim Botânico, Porto Alegre - RS, 90610-000 · CNES 2232928

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do Metabolismo

Hospital de Clínicas de Porto Alegre (HCPA)

Rua Ramiro Barcelos, 2350 Bloco A - Av. Protásio Alves, 211 - Bloco B e C - Santa Cecília, Porto Alegre - RS, 90035-903 · CNES 2237601

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Universitário da UFSC (HU-UFSC)

R. Profa. Maria Flora Pausewang - Trindade, Florianópolis - SC, 88036-800 · CNES 2560356

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do Metabolismo

Hospital das Clínicas da FMUSP

R. Dr. Ovídio Pires de Campos, 225 - Cerqueira César, São Paulo - SP, 05403-010 · CNES 2077485

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital de Clínicas da UNICAMP

R. Vital Brasil, 251 - Cidade Universitária, Campinas - SP, 13083-888 · CNES 2748223

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital de Clínicas de Ribeirão Preto (HCRP-USP)

R. Ten. Catão Roxo, 3900 - Vila Monte Alegre, Ribeirão Preto - SP, 14015-010 · CNES 2082187

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Instituto da Criança e do Adolescente (ICr-HCFMUSP)

Av. Dr. Enéas Carvalho de Aguiar, 647 - Cerqueira César, São Paulo - SP, 05403-000 · CNES 2081695

Serviço de Referência

Rota
Erros Inatos do Metabolismo

UNIFESP / Hospital São Paulo

R. Napoleão de Barros, 715 - Vila Clementino, São Paulo - SP, 04024-002 · CNES 2688689

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do Metabolismo
Sobre os centros SUS: Estes centros são habilitados pelo Ministério da Saúde como Serviços de Referência em Doenças Raras ou Serviços de Atenção Especializada. O atendimento é pelo SUS, com encaminhamento da rede de atenção básica.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

🟢 Recrutando agora

1 pesquisa recrutando participantes. Converse com seu médico sobre a possibilidade de participar.

Outros ensaios clínicos

🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
0 papers (10 anos)
#1

Underrecognized need for early detection of inborn errors of metabolism in China: A population-based study of 14.31 million residents (2012-2023).

Molecular genetics and metabolism2026 Jan

Inborn errors of metabolism (IEMs) are a major subgroup of rare diseases, comprising over 1000 genetic disorders that disrupt essential biochemical pathways. Globally, they cause an estimated 23,500 childhood deaths annually. Despite diagnostic advances indicating a cumulative incidence of ∼1 in 800 births, population-based data from China remain scarce. We conducted a population-based study of 14.31 million permanent residents in the Great Beijing Area (2012-2023) using the municipal disease registry. Rare diseases were identified using ICD-10 codes mapped to the 2018 and 2023 National Rare Disease Catalog, from which 13 classified as IEMs were included in this study. Age-standardized incidence rates (ASIRs) were calculated, and disease patterns were compared with international newborn screening (NBS) data. Of 12,371 rare disease diagnoses, 314 (2.5 %) were IEMs. The ASIR was 0.180 per 100,000 person-years (95 % CI: 0.031-0.565) in 2012 and remained stable at 0.159 (95 % CI: 0.023-0.532) in 2023. Early-onset cases (<1 year) comprised 41.7 %. The mean diagnostic age was 11.0 years, with a median of 1.0 year. Methylmalonic acidemia without homocystinuria (40.8 %), phenylketonuria (29.9 %), and Fabry disease (6.7 %) were most common; males accounted for 60.5 % of cases. Although the prevalence of certain IEMs was broadly consistent with global data, the markedly low ASIR suggests substantial underdiagnosis of IEMs in China. This first large-scale, population-based study of IEMs in China reveals underestimation of true disease burden. Expanding and standardizing NBS coverage, broadening genetic testing, implementing mandatory screening, and integrating long-term care into health systems are urgent policy priorities.

#2

Nutritional management of metabolic disorders in neonates and infants in Saudi Arabia: consensus recommendations.

Orphanet journal of rare diseases2025 Nov 17

Inborn errors of metabolism (IEM) are inherited disorders affecting metabolism which can result in intellectual disability, cognitive impairment or death if left untreated. Nutritional management plays a major role in ensuring adequate growth, nutritional status and development, reducing levels of toxic metabolites, preventing deficiencies and avoiding catabolism in infants with IEM. The aim of this consensus is to provide recommendations for nutritional management of metabolic diseases in neonates and infants in Saudi Arabia, where a high frequency of IEM has been reported.Consensus generation was performed using the Delphi method. Six metabolic dietitians from five hospitals across KSA formed the expert panel. Two face-to face meetings and one virtual meeting were conducted to generate consensus statements. Voting was conducted anonymously on SurveyMonkey to determine the level of agreement with each recommendation.The expert panel reached consensus on 105 recommendations relating to the nutritional management of metabolic disorders, focusing on PA, MMA, GA1, PKU, MSUD, VLCAD, and HCU.These recommendations will facilitate more consistent management of metabolic patients across Saudi Arabia and strive to highlight ongoing challenges faced by dietitians, patients, and caregivers. Future work should focus on outcomes associated with dietary management strategies in Saudi Arabia.

#3

[A case of cblF type methylmalonic aciduria and homocystinuria].

Zhonghua er ke za zhi = Chinese journal of pediatrics2025 Oct 14

患儿,男,1岁7个月,以反复发热、呼吸道感染起病,全身皮肤色黑,血液酯酰肉碱谱显示血液游离肉碱30.84 μmol/L,丙酰肉碱5.34 μmol/L,丙酰肉碱/游离肉碱0.96,丙酰肉碱/乙酰肉碱0.45,均升高,尿液甲基丙二酸和血同型半胱氨酸升高。患儿LMDRD1基因存在c.829C>T(p.Arg227Ter)和c.1156C>T(p.Arg368Ter)复合杂合变异,分别来源于父母,确诊为cblF 型甲基丙二酸尿症。患儿经口服甲钴胺、叶酸、左卡尼汀治疗后,病情逐渐好转,随访5个月后患儿血同型半胱氨酸降至17.67 μmol/L,尿液甲基丙二酸浓度降至基准值2.24倍,肺炎治愈。.

#4

Analysis of hydroxocobalamin dosage in patients with CblC deficiency.

Orphanet journal of rare diseases2025 Aug 21

cblC deficiency is the most common organic acidemia in China. Hydroxocobalamin (OHCbl) is the main important therapeutic approach, while no approved protocols on its dosage during stable periods exist. This study aims to analyze OHCbl dosage and explore its influencing factors, providing reference for the option of OHCbl dosage. A total of 730 patients with cblC deficiency during stable periods were enrolled. Univariate analysis and multiple linear regression analysis were used to investigate the correlation between OHCbl dosage and tandem mass spectrometry (MS/MS)-based newborn screening (NBS), disease onset as well as MMACHC gene mutation. Univariate analysis revealed no significant difference in OHCbl dosage between whether patients were diagnosed by MS/MS-based NBS or not, while significant differences were found based on disease onset and the presence of c.482G > A variant. Multiple linear regression analysis further identified disease onset and the c.482G > A variant as independent factors influencing OHCbl dosage. The median OHCbl dosage during stable periods was 1.18 mg/kg/week, with 0.31 mg/kg/week in patients with the c.482G > A variant and 1.37 mg/kg/week in those without. However, in patients carrying the c.482G > A variant, there was no significant difference in the OHCbl dosage between those with and without disease onset, while in patients without the c.482G > A variant, those with disease onset had a higher OHCbl dosage compared to those without. The study demonstrated the independent influencing factors of OHCbl dosage in patients with cblC deficiency and put forward corresponding reference for the option of OHCbl dosage.

#5

Clinical and molecular spectrum of patients with methylmalonic acidemia and homocysteinemia complicated by cardiovascular manifestations.

Orphanet journal of rare diseases2025 Aug 19

To investigate the clinical characteristics, treatment response, and prognosis of patients with methylmalonic acidemia (MMA) and homocysteinemia complicated by cardiovascular manifestations and to raise awareness regarding MMA and homocysteinemia. A total of 16 children diagnosed with MMA and homocysteinemia with cardiovascular manifestations who were admitted to the Department of Pediatrics of the Second Hospital of Hebei Medical University from June 2018 to October 2024 were retrospectively analyzed. All 16 patients had varying degrees of neurological manifestations, and all had cardiovascular manifestations, 3 patients were diagnosed with MMA and homocysteinemia by newborn screening and received conventional treatment, the remaining 13 patients had nausea, vomiting, anemia, recurrent pneumonitis, respiratory distress, and lethargy as their first symptoms. Cardiovascular complications were found between the ages of 2 months and 12 years, with 9 patients having pulmonary hypertension, 7 having hypertension, and 5 having non-compaction of ventricular myocardium. Fourteen of these cases were confirmed to have CblC-type methylmalonic acidemia caused by mutations in the MMACHC gene by genetic testing. The most common mutations were c.80A > G (p.Q27R) (8 cases) and c.609G > A (p.W203X) (8 cases). Cardiovascular manifestation is uncommon in patients with MMA and homocysteinemia, but it is usually critical cause of death. When unexplained pulmonary hypertension or hypertension occurs, MMA and homocysteinemia should be suspected, especially when accompanied by manifestations of other systems.

Publicações recentes

Ver todas no PubMed

📚 EuropePMCmostrando 168

2025

Case Report: Dilated cardiomyopathy as the initial presentation in an adult with late-onset CblC defect.

Frontiers in cardiovascular medicine
2025

Incidence of Organic Acid Disorders in 13 Million Chinese Newborns: A Systematic Review and Meta-Analysis.

International journal of neonatal screening
2025

Cobalamin J Disorder in a Teenage Boy with Recurrent Abdominal Pain Attacks: A Case Report and Literature Review.

Molecular syndromology
2026

Underrecognized need for early detection of inborn errors of metabolism in China: A population-based study of 14.31 million residents (2012-2023).

Molecular genetics and metabolism
2025

Experimental insights into MMACHC variants using a novel minigene system.

Molecular genetics and metabolism
2025

Nutritional management of metabolic disorders in neonates and infants in Saudi Arabia: consensus recommendations.

Orphanet journal of rare diseases
2025

Case Report: Cerebellar microhemorrhages: an underrecognized feature of MMA-HC revealed by high-field 7.0 T MRI.

Frontiers in radiology
2025

[A case of cblF type methylmalonic aciduria and homocystinuria].

Zhonghua er ke za zhi = Chinese journal of pediatrics
2025

Analysis of hydroxocobalamin dosage in patients with CblC deficiency.

Orphanet journal of rare diseases
2025

Clinical and molecular spectrum of patients with methylmalonic acidemia and homocysteinemia complicated by cardiovascular manifestations.

Orphanet journal of rare diseases
2025

Retinal Changes in Early-Onset cblC Methylmalonic Acidemia Identified Through Expanded Newborn Screening: Highlights from a Case Study and Literature Review.

Genes
2025

Variable phenotypes and outcomes associated with the MMACHC c.1A>G variant in Chinese patients with combined methylmalonic acidemia and homocystinuria cblC type.

Molecular genetics and metabolism
2025

Missense mutations in MMACHC protein from cblC disease affect its conformational stability and vitamin B12-binding activity: The example of R161Q mutation.

Molecular genetics and metabolism
2025

Propionyl Carnitine Metabolic Profile: Optimizing the Newborn Screening Strategy Through Customized Cut-Offs.

Metabolites
2025

New genetic tools to define the pathophysiology of inborn errors of cobalamin metabolism impacting mammalian development.

Differentiation; research in biological diversity
2025

Spectrum of genetic mutations in methylmalonic aciduria among Iranian patients.

Scientific reports
2025

Clinical diagnosis, treatment, and genetic analysis of adolescent onset holocarboxylase synthetase deficiency and cobalamin C deficiency: A case report and literature review.

Metabolism open
2025

Retinal dimples in a case of adult-onset methylmalonic acidemia with homocystinuria: A new finding.

Journal francais d'ophtalmologie
2025

Methylmalonic acidemia with homocystinuria in acute myeloid leukemia: a case report.

BMC pediatrics
2025

Disorder of intracellular cobalamin metabolism: Importance of rapid diagnostic illustrated by a case report of early-onset methylmalonic aciduria and homocystinuria, cobalamin C type.

Heliyon
2024

A case series of Cypriot patients with CblC defect: Clinical, biochemical and molecular characteristics.

Molecular genetics and metabolism reports
2024

Kidney-Limited Microangiopathy Associated with Methionine Synthase (Cobalamin G) Deficiency in a Pediatric Patient: Case Report and Review of the Literature.

Glomerular diseases
2024

Late-onset renal TMA and tubular injury in cobalamin C disease: a report of three cases and literature review.

BMC nephrology
2024

Evaluation of the clinical, biochemical, and molecular spectrum of Cobalamin C (CblC) defect in 33 patients from Pakistan.

Scandinavian journal of clinical and laboratory investigation
2025

Improved biochemical and neurodevelopmental profiles with high-dose hydroxocobalamin therapy in cobalamin C defect.

Journal of inherited metabolic disease
2024

Renal Replacement Therapy in Methylmalonic Aciduria-Related Metabolic Failure: Case Report and Literature Review.

Journal of clinical medicine
2024

Concurrent combined methylmalonic acidemia and homocystinuria with down syndrome in a Chinese preschool Child: An in-depth case report and literature review.

Heliyon
2024

A novel amino acid metabolism-related gene signature to predict the overall survival of esophageal squamous cell carcinoma patients.

Journal of thoracic disease
2024

Outcomes after newborn screening for propionic and methylmalonic acidemia and homocystinurias.

Journal of inherited metabolic disease
2024

The MMACHC variant c.158T>C: Mild clinical and biochemical phenotypes and marked hydroxocobalamin response in cblC patients.

Molecular genetics and metabolism
2024

Clinical and Molecular Genetic Analysis with Methylmalonic Acidemia Combined with Homocystinuria.

Clinical laboratory
2024

METHYLATION-ASSOCIATED PATHWAYS IN MACULAR TELANGIECTASIA TYPE 2 AND OPHTHALMOLOGIC FINDINGS IN PATIENTS WITH GENETIC METHYLATION DISORDERS.

Retina (Philadelphia, Pa.)
2024

Late-onset methylmalonic acidemia and homocysteinemia (cblC disease): systematic review.

Orphanet journal of rare diseases
2023

Interaction of Glutathione with MMACHC Arginine-Rich Pocket Variants Associated with Cobalamin C Disease: Insights from Molecular Modeling.

Biomedicines
2024

Variable phenotypes and outcomes associated with the MMACHC c.482G > A mutation: follow-up in a large CblC disease cohort.

World journal of pediatrics : WJP
2023

Clinical, Biochemical and Molecular Features of a Cohort of 8 Patients with Inherited Disorders of Vitamin B12 Metabolism in a Metabolic Reference Center.

Endocrine, metabolic &amp; immune disorders drug targets
2023

Late-onset cblC defect: clinical, biochemical and molecular analysis.

Orphanet journal of rare diseases
2023

Characteristics, differential diagnosis, individualized treatment, and prevention of hyperhomocysteinemia in newborns.

European journal of medical genetics
2023

Combined Newborn Screening Allows Comprehensive Identification also of Attenuated Phenotypes for Methylmalonic Acidurias and Homocystinuria.

Nutrients
2024

Clinical and Molecular Spectrum of Patients with Methylmalonic Acidemia.

Indian journal of pediatrics
2023

Abnormal chondrocyte development in a zebrafish model of cblC syndrome restored by an MMACHC cobalamin binding mutant.

Differentiation; research in biological diversity
2023

A regionally adapted HRM-based technique to screen MMACHC carriers for methylmalonic acidemia with homocystinuria in Shandong Province, China.

Intractable &amp; rare diseases research
2023

Development of a Universal Second-Tier Newborn Screening LC-MS/MS Method for Amino Acids, Lysophosphatidylcholines, and Organic Acids.

Analytical chemistry
2023

Abnormal chondrocyte intercalation in a zebrafish model of cblC syndrome restored by an MMACHC cobalamin binding mutant.

bioRxiv : the preprint server for biology
2022

Acquired Vitamin B12 Deficiency in Newborns: Positive Impact on Newborn Health through Early Detection.

Nutrients
2022

A teenager with combined methylmalonic aciduria and homocystinuria (CblC type) presenting with neurological symptoms and congenital heart diseases: a case report.

Neurocase
2022

Late-onset cblC deficiency around puberty: a retrospective study of the clinical characteristics, diagnosis, and treatment.

Orphanet journal of rare diseases
2022

Late-onset cobalamin C disease: rare but treatable.

Practical neurology
2022

Toxic Metabolites and Inborn Errors of Amino Acid Metabolism: What One Informs about the Other.

Metabolites
2022

Identification of MMACHC and ZEB2 mutations causing coexistent cobalamin C disease and Mowat-Wilson syndrome in a 2-year-old girl.

Clinica chimica acta; international journal of clinical chemistry
2022

Investigation on a MMACHC mutant from cblC disease: The c.394C>T variant.

Biochimica et biophysica acta. Proteins and proteomics
2022

Isolated psychiatric presentation of cobalamin C type disorder with novel mutation in middle childhood: A case report.

Asian journal of psychiatry
2022

Epimutations in both the TESK2 and MMACHC promoters in the Epi-cblC inherited disorder of intracellular metabolism of vitamin B12.

Clinical epigenetics
2022

Inherited metabolic diseases mimicking hereditary spastic paraplegia (HSP): a chance for treatment.

Neurogenetics
2022

The genotype analysis and prenatal genetic diagnosis among 244 pedigrees with methylmalonic aciduria in China.

Taiwanese journal of obstetrics &amp; gynecology
2022

Inherited defects of cobalamin metabolism.

Vitamins and hormones
2022

Intracellular processing of vitamin B12 by MMACHC (CblC).

Vitamins and hormones
2022

Diagnosis of inborn errors of metabolism within the expanded newborn screening in the Madrid region.

JIMD reports
2022

The Follow-Up of Chinese Patients in cblC Type Methylmalonic Acidemia Identified Through Expanded Newborn Screening.

Frontiers in genetics
2022

Cranial Magnetic Resonance Imaging Findings in Hypotonic Infants with Cobalamin Deficiency and Combined Methylmalonic Aciduria and Homocystinuria.

Klinische Padiatrie
2022

Adult-onset CblC deficiency: a challenging diagnosis involving different adult clinical specialists.

Orphanet journal of rare diseases
2022

Neurodevelopmental and neuropsychiatric disorders in cobalamin C disease: a case report and review of the literature.

Cold Spring Harbor molecular case studies
2022

Mutations in Hcfc1 and Ronin result in an inborn error of cobalamin metabolism and ribosomopathy.

Nature communications
2022

Selective screening for inborn errors of metabolism by tandem mass spectrometry at Sohag University Hospital, Egypt.

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie
2022

Prevalence of methylmalonic acidemia among newborns and the clinical-suspected population: a meta-analyse.

The journal of maternal-fetal &amp; neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians
2021

Prenatal diagnosis of combined methylmalonic acidemia and homocystinuria cobalamin C type using clinical exome sequencing and targeted gene analysis.

Molecular genetics &amp; genomic medicine
2021

Combined Methylmalonic Aciduria and Homocystinuria Presenting as Pulmonary Hypertension.

Indian journal of pediatrics
2021

Determination of Cytokines and Oxidative Stress Biomarkers in Cognitive Impairment Induced by Methylmalonic Acidemia.

Neuroimmunomodulation
2021

Pilot Study on Neonatal Screening for Methylmalonic Acidemia Caused by Defects in the Adenosylcobalamin Synthesis Pathway and Homocystinuria Caused by Defects in Homocysteine Remethylation.

International journal of neonatal screening
2021

PRDX1 gene-related epi-cblC disease is a common type of inborn error of cobalamin metabolism with mono- or bi-allelic MMACHC epimutations.

Clinical epigenetics
2021

A 13-Year-Old Boy With Subacute-Onset Spastic Gait.

JAMA neurology
2021

Absence of MMACHC in peripheral retinal cells does not lead to an ocular phenotype in mice.

Biochimica et biophysica acta. Molecular basis of disease
2021

Late-onset methylmalonic acidemia and homocysteinemia.

Nutricion hospitalaria
2021

Preimplantation Genetic Testing for Rare Inherited Disease of MMA-CblC: an Unaffected Live Birth.

Reproductive sciences (Thousand Oaks, Calif.)
2021

Epimutation of MMACHC compound to a genetic mutation in cblC cases.

Molecular genetics &amp; genomic medicine
2021

Implementation of second-tier tests in newborn screening for the detection of vitamin B12 related acquired and genetic disorders: results on 258,637 newborns.

Orphanet journal of rare diseases
2021

The lysosomal protein ABCD4 can transport vitamin B12 across liposomal membranes in vitro.

The Journal of biological chemistry
2021

Combined Genome, Transcriptome and Metabolome Analysis in the Diagnosis of Childhood Cerebellar Ataxia.

International journal of molecular sciences
2021

Redox-Linked Coordination Chemistry Directs Vitamin B12 Trafficking.

Accounts of chemical research
2021

Cobalamin J disease detected on newborn screening: Novel variant and normal neurodevelopmental course.

American journal of medical genetics. Part A
2021

Value of amniotic fluid homocysteine assay in prenatal diagnosis of combined methylmalonic acidemia and homocystinuria, cobalamin C type.

Orphanet journal of rare diseases
2021

Hemolytic Uremic Syndrome Due to Methylmalonic Acidemia and Homocystinuria in an Infant: A Case Report and Literature Review.

Children (Basel, Switzerland)
2021

MMADHC premature termination codons in the pathogenesis of cobalamin D disorder: Potential of translational readthrough reconstitution.

Molecular genetics and metabolism reports
2021

A high frequency and geographical distribution of MMACHC R132* mutation in children with cobalamin C defect.

Amino acids
2021

Outcomes of patients with cobalamin C deficiency: A single center experience.

JIMD reports
2020

[Remethylation disorders: about two cases].

Annales de biologie clinique
2021

Ocular findings in a patient with methylmalonic acidemia and homocystinuria.

Journal francais d'ophtalmologie
2020

Expanded Screening of One Million Swedish Babies with R4S and CLIR for Post-Analytical Evaluation of Data.

International journal of neonatal screening
2020

Proteinuria as a presenting sign of combined methylmalonic acidemia and homocysteinemia: case report.

BMC medical genetics
2020

Analysis of 70 patients with hydrocephalus due to cobalamin C deficiency.

Neurology
2020

Mouse models to study the pathophysiology of combined methylmalonic acidemia and homocystinuria, cblC type.

Developmental biology
2020

Development of infantile tremor syndrome after initiation of hydroxycobalamin treatment in an infant with a late diagnosis of cobalamin C disorder.

JIMD reports
2020

Variable phenotypes and outcomes associated with the MMACHC c.609G>A homologous mutation: long term follow-up in a large cohort of cases.

Orphanet journal of rare diseases
2020

Mutation analysis, treatment and prenatal diagnosis of Chinese cases of methylmalonic acidemia.

Scientific reports
2020

The human B12 trafficking protein CblC processes nitrocobalamin.

The Journal of biological chemistry
2020

Pulmonary hypertension in late-onset Methylmalonic Aciduria and Homocystinemia: a case report.

BMC pediatrics
2020

Inborn errors of metabolism detectable by tandem mass spectrometry in Beijing.

Journal of pediatric endocrinology &amp; metabolism : JPEM
2020

Brain Circuit Alterations and Cognitive Disability in Late-Onset Cobalamin D Disorder.

Journal of clinical medicine
2020

Late-onset cobalamin C disease presenting with acute progressive polyneuropathy.

Muscle &amp; nerve
2020

Rapid screening of MMACHC gene mutations by high-resolution melting curve analysis.

Molecular genetics &amp; genomic medicine
2020

The vitamin B12 processing enzyme, mmachc, is essential for zebrafish survival, growth and retinal morphology.

Human molecular genetics
2020

Cobalamin c deficiency associated with antifactor h antibody-associated hemolytic uremic syndrome in a young adult.

BMC nephrology
2020

High-dose hydroxocobalamin achieves biochemical correction and improvement of neuropsychiatric deficits in adults with late onset cobalamin C deficiency.

JIMD reports
2020

Generation of a Human iPSC line (SDQLCHi021-A) from a patient with methylmalonic acidemia cblC type carrying compound heterozygous mutations in MMAHC gene.

Stem cell research
2020

The correlation between the evolution of bilateral basal ganglia hemorrhage using MR imaging and neurological damage recovery in an infant with methylmalonic aciduria.

Brain &amp; development
2020

Methylmalonic Acidemia Complicated by Homocystinuria Diseases: a Report of Three Cases.

Advances in therapy
2020

Noninvasive prenatal diagnosis of cobalamin C (cblC) deficiency through target region sequencing of cell-free DNA in maternal plasma.

Prenatal diagnosis
2019

Isolated subacute combined degeneration in late-onset cobalamin C deficiency in children: Two case reports and literature review.

Medicine
2019

Parenteral hydroxocobalamin dose intensification in five patients with different types of early onset intracellular cobalamin defects: Clinical and biochemical responses.

JIMD reports
2019

Prospective evaluation of pregnancy outcome in an Italian woman with late-onset combined homocystinuria and methylmalonic aciduria.

BMC pregnancy and childbirth
2021

Hyperhomocysteinemia: a trigger for complement-mediated TMA?

Acta clinica Belgica
2019

Mutation spectrum of MMACHC in Chinese pediatric patients with cobalamin C disease: A case series and literature review.

European journal of medical genetics
2019

Do not Miss Rare and Treatable Cause of Early-Onset Hemolytic Uremic Syndrome: Cobalamin C Deficiency.

Nephron
2019

Clinical feature and outcome of late-onset cobalamin C disease patients with neuropsychiatric presentations: a Chinese case series.

Neuropsychiatric disease and treatment
2019

The Value of 1H-MRS and MRI in Combined Methylmalonic Aciduria and Homocystinuria.

Journal of computer assisted tomography
2018

Molecular genetic characterization of cblC defects in 126 pedigrees and prenatal genetic diagnosis of pedigrees with combined methylmalonic aciduria and homocystinuria.

BMC medical genetics
2018

Favorable course of previously undiagnosed Methylmalonic Aciduria with Homocystinuria (cblC type) presenting with pulmonary hypertension and aHUS in a young child: a case report.

Italian journal of pediatrics
2019

Cobalamin D Deficiency Identified Through Newborn Screening.

JIMD reports
2018

Improving the diagnosis of cobalamin and related defects by genomic analysis, plus functional and structural assessment of novel variants.

Orphanet journal of rare diseases
2018

Pulmonary embolism in a child with combined methylmalonic acidemia and homocystinuria.

Pediatric investigation
2018

Diversity in the incidence and spectrum of organic acidemias, fatty acid oxidation disorders, and amino acid disorders in Asian countries: Selective screening vs. expanded newborn screening.

Molecular genetics and metabolism reports
2018

Methylmalonic acidemia: Current status and research priorities.

Intractable &amp; rare diseases research
2018

Transcellular transport of cobalamin in aortic endothelial cells.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology
2018

Expanded Newborn Screening for Inborn Errors of Metabolism and Genetic Characteristics in a Chinese Population.

Frontiers in genetics
2018

Whole-exome Sequencing Helps the Diagnosis and Treatment in Children with Neurodevelopmental Delay Accompanied Unexplained Dyspnea.

Scientific reports
2018

Hemolytic uremic syndrome with dual caution in an infant: cobalamin C defect and complement dysregulation successfully treated with eculizumab.

Pediatric nephrology (Berlin, Germany)
2018

Late-onset cobalamin C deficiency Chinese sibling patients with neuropsychiatric presentations.

Metabolic brain disease
2018

Serial Magnetic Resonance Imaging Changes in a Patient With Late-Onset Cobalamin C Disease With a Misdiagnosis of Metachromatic Leukodystrophy.

JAMA neurology
2018

Atypical adult-onset methylmalonic acidemia and homocystinuria presenting as hemolytic uremic syndrome.

CEN case reports
2017

Identification of ABC transporters acting in vitamin B12 metabolism in Caenorhabditis elegans.

Molecular genetics and metabolism
2018

Skin lesions in a patient with Cobalamin C disease in poor metabolic control.

Journal of inherited metabolic disease
2017

Diagnosis of cobalamin C deficiency with renal abnormality from onset in a Chinese child by next generation sequencing: A case report.

Experimental and therapeutic medicine
2018

Effects of medical food leucine content in the management of methylmalonic and propionic acidemias.

Current opinion in clinical nutrition and metabolic care
2019

Mutation of the MMADHC gene in adult-onset cobalamin D deficiency: A report of 2 potentially treatable cases.

Neurologia
2017

Quantitative Assessment of Microstructural Changes of the Retina in Infants With Congenital Zika Syndrome.

JAMA ophthalmology
2018

Thrombotic microangiopathy and breastfeeding: where is the link? Questions.

Pediatric nephrology (Berlin, Germany)
2017

Milder clinical and biochemical phenotypes associated with the c.482G>A (p.Arg161Gln) pathogenic variant in cobalamin C disease: Implications for management and screening.

Molecular genetics and metabolism
2018

Cobalamin disorder CblC presenting with hemolytic uremic syndrome and pulmonary hypertension.

Nefrologia
2017

Clinical or ATPase domain mutations in ABCD4 disrupt the interaction between the vitamin B12-trafficking proteins ABCD4 and LMBD1.

The Journal of biological chemistry
2017

Optical coherence tomography morphology and evolution in cblC disease-related maculopathy in a case series of very young patients.

Acta ophthalmologica
2017

X-Linked Cobalamin Disorder (HCFC1) Mimicking Nonketotic Hyperglycinemia With Increased Both Cerebrospinal Fluid Glycine and Methylmalonic Acid.

Pediatric neurology
2017

Combined methylmalonic acidemia and homocysteinemia presenting predominantly with late-onset diffuse lung disease: a case series of four patients.

Orphanet journal of rare diseases
2018

Neuropsychological implications of Cobalamin C (CblC) disease in Hispanic children detected through newborn screening.

Applied neuropsychology. Child
2016

Spectrum of ocular manifestations in cobalamin C and cobalamin A types of methylmalonic acidemia.

Ophthalmic genetics
2017

Targeted exome sequencing for the identification of complementation groups in methylmalonic aciduria: A south Indian experience.

Clinical biochemistry
2017

Renal thrombotic microangiopathy in patients with cblC defect: review of an under-recognized entity.

Pediatric nephrology (Berlin, Germany)
2016

The remarkable S. Harvey Mudd - A reminiscence.

Molecular genetics and metabolism
2015

REVERSIBLE CLINICAL AND MAGNETIC RESONANCE IMAGING FINDINGS IN LATE-ONSET COBALAMIN C DEFECT.

Genetic counseling (Geneva, Switzerland)
2016

Ophthalmic Manifestations and Long-Term Visual Outcomes in Patients with Cobalamin C Deficiency.

Ophthalmology
2016

COBALAMIN C DEFICIENCY WITH INFANTILE SPASM AND CUTANEOUS FINDINGS: A UNIQUE CASE.

Genetic counseling (Geneva, Switzerland)
2015

Cobalamin C Deficiency-Associated Pigmentary Retinopathy.

JAMA ophthalmology
2015

Cobalamin C Deficiency Shows a Rapidly Progressing Maculopathy With Severe Photoreceptor and Ganglion Cell Loss.

Investigative ophthalmology &amp; visual science
2016

Clinical presentation, gene analysis and outcomes in young patients with early-treated combined methylmalonic acidemia and homocysteinemia (cblC type) in Shandong province, China.

Brain &amp; development
2015

Genetic analysis of four cases of methylmalonic aciduria and homocystinuria, cblC type#.

International journal of clinical and experimental pathology
2015

Heptadecanoylcarnitine (C17) a novel candidate biomarker for newborn screening of propionic and methylmalonic acidemias.

Clinica chimica acta; international journal of clinical chemistry
2015

Structure of Human B12 Trafficking Protein CblD Reveals Molecular Mimicry and Identifies a New Subfamily of Nitro-FMN Reductases.

The Journal of biological chemistry
2015

[Relationship of genotypes with clinical phenotypes and outcomes in children with cobalamin C type combined methylmalonic aciduria and homocystinuria].

Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics
2015

MMACHC gene mutation in familial hypogonadism with neurological symptoms.

Gene
2015

Clinical characteristics of hemolytic uremic syndrome secondary to cobalamin C disorder in Chinese children.

World journal of pediatrics : WJP
2015

Prenatal diagnosis using genetic sequencing and identification of a novel mutation in MMACHC.

BMC medical genetics
2015

[Combined methylmalonic acidemia and homocystinuria; a case report].

Nutricion hospitalaria
2015

Cobalamin C Disease Missed by Newborn Screening in a Patient with Low Carnitine Level.

JIMD reports
2015

Ocular disease in the cobalamin C defect: a review of the literature and a suggested framework for clinical surveillance.

Molecular genetics and metabolism
2015

Predictors of survival in children with methymalonic acidemia with homocystinuria in Beijing, China: a prospective cohort study.

Indian pediatrics
2015

Targeted metabolomics in the expanded newborn screening for inborn errors of metabolism.

Molecular bioSystems
2015

Whole Exome Sequencing Identifies an Adult-Onset Case of Methylmalonic Aciduria and Homocystinuria Type C (cblC) with Non-Syndromic Bull's Eye Maculopathy.

Ophthalmic genetics
2015

[A case of late-onset cobalamin C disease (methylmalonic aciduria and homocystinuria, cobalamin C type)].

Rinsho shinkeigaku = Clinical neurology
2015

The proteome of cblC defect: in vivo elucidation of altered cellular pathways in humans.

Journal of inherited metabolic disease

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Homocistinúria sem acidúria metilmalônica.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Homocistinúria sem acidúria metilmalônica

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Underrecognized need for early detection of inborn errors of metabolism in China: A population-based study of 14.31 million residents (2012-2023).
    Molecular genetics and metabolism· 2026· PMID 41371076mais citado
  2. Nutritional management of metabolic disorders in neonates and infants in Saudi Arabia: consensus recommendations.
    Orphanet journal of rare diseases· 2025· PMID 41250200mais citado
  3. [A case of cblF type methylmalonic aciduria and homocystinuria].
    Zhonghua er ke za zhi = Chinese journal of pediatrics· 2025· PMID 41087850mais citado
  4. Analysis of hydroxocobalamin dosage in patients with CblC deficiency.
    Orphanet journal of rare diseases· 2025· PMID 40841656mais citado
  5. Clinical and molecular spectrum of patients with methylmalonic acidemia and homocysteinemia complicated by cardiovascular manifestations.
    Orphanet journal of rare diseases· 2025· PMID 40830795mais citado
  6. Data accuracy in the European Cystic Fibrosis Society Patient Registry: results of an on-site data validation project.
    Orphanet J Rare Dis· 2025· PMID 41327420recente
  7. Pulmonary features and stage of disease in adult patients with hyper-IgE syndrome: a single-centre clinical study and literature review.
    Orphanet J Rare Dis· 2025· PMID 40462219recente
  8. Safety of beta-blocker discontinuation after acute coronary syndromes with preserved or mildly reduced left ventricular ejection fraction: a target trial emulation from a real-world cohort.
    Eur J Prev Cardiol· 2025· PMID 39454630recente
  9. Health Disparities among adults cared for at an urban cystic fibrosis program.
    Orphanet J Rare Dis· 2021· PMID 34332588recente
  10. Deliberate paradigm shift in research in rare neurodevelopmental disorders.
    Orphanet J Rare Dis· 2021· PMID 34107995recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:622(Orphanet)
  2. MONDO:0018964(MONDO)
  3. GARD:16537(GARD (NIH))
  4. Variantes catalogadas(ClinVar)
  5. Busca completa no PubMed(PubMed)
  6. Q56014237(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Homocistinúria sem acidúria metilmalônica
Compêndio · Raras BR

Homocistinúria sem acidúria metilmalônica

ORPHA:622 · MONDO:0018964
🇧🇷 Brasil SUS
Triagem
MS/MS — acilcarnitinas + ácidos orgânicos
PNTN
Fase 2
Incidência BR
1:20.000
Geral
Prevalência
<1 / 1 000 000
Casos
73 casos conhecidos
Herança
Autosomal recessive
CID-10
E72.1 · Distúrbios do metabolismo dos aminoácidos que contêm enxofre
CID-11
Início
All ages
Prevalência
0.0 (Worldwide)
MedGen
UMLS
C4303479
Repurposing
2 candidatos
betainenitric oxide donor
penicillamine-(D)chelating agent
Wikidata
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades